Spike-specific antibodies are central to effective COVID19 immunity. Research efforts have focused on antibodies that neutralize the ACE2-Spike interaction but not on non-neutralizing antibodies. Anti

NIAID Data Ecosystem50

Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses

T细胞交叉反应性

冠状病毒免疫反应

We used the viral functional expansion of specific T cells (ViraFEST) platform to identify T cell responses crossreactive for the spike (S) glycoproteins of SARS-CoV-2 and common cold coronaviruses (C

Immunology Database and Analysis Portal2025-10-30 更新20

Comparison of IgG antibodies to SARS-CoV-2 spike and RBD proteins in December 2020 and February 2021.

冠状病毒免疫反应

抗体动态分析

Comparison of IgG antibodies to SARS-CoV-2 spike and RBD proteins in December 2020 and February 2021.

NIAID Data Ecosystem70

Design of novel multi-epitope vaccines against severe acute respiratory syndrome validated through multistage molecular interaction and dynamics

表位疫苗设计

冠状病毒免疫反应

Severe acute respiratory syndrome (SARS) is endemic in South China and is continuing to spread worldwide since the 2003 outbreak, affecting human population of 37 countries till present. SARS is cause

NIAID Data Ecosystem30

Boosting of the SARS-CoV-2-specific immune response after vaccination with single-dose Sputnik Light vaccine

资源简介：

相关数据集